On Monday, Checkpoint Therapeutics Inc (NASDAQ: CKPT) opened lower -5.70% from the last session, before settling in for the closing price of $4.21. Price fluctuations for CKPT have ranged from $1.36 to $4.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -47.67% over the past five years. Company’s average yearly earnings per share was noted 71.45% at the time writing. With a float of $40.57 million, this company’s outstanding shares have now reached $45.10 million.
Let’s look at the performance matrix of the company that is accounted for 23 employees. In terms of profitability, gross margin is -45168.08%, operating margin of -79817.02%, and the pretax margin is -98868.09%.
Checkpoint Therapeutics Inc (CKPT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Checkpoint Therapeutics Inc is 16.91%, while institutional ownership is 16.23%. The most recent insider transaction that took place on Jun 26 ’24, was worth 50,450. In this transaction CEO, President and Director of this company sold 24,610 shares at a rate of $2.05, taking the stock ownership to the 1,977,170 shares. Before that another transaction happened on Jun 26 ’24, when Company’s Chief Financial Officer sold 13,038 for $2.06, making the entire transaction worth $26,858. This insider now owns 672,186 shares in total.
Checkpoint Therapeutics Inc (CKPT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 71.45% per share during the next fiscal year.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators
Check out the current performance indicators for Checkpoint Therapeutics Inc (CKPT). In the past quarter, the stock posted a quick ratio of 0.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3914.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach 0.14 in one year’s time.
Technical Analysis of Checkpoint Therapeutics Inc (CKPT)
Checkpoint Therapeutics Inc (NASDAQ: CKPT) saw its 5-day average volume 0.83 million, a positive change from its year-to-date volume of 0.55 million. As of the previous 9 days, the stock’s Stochastic %D was 46.80%. Additionally, its Average True Range was 0.29.
During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 78.28%, which indicates a significant increase from 56.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.57% in the past 14 days, which was lower than the 63.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.31, while its 200-day Moving Average is $2.36. Nevertheless, the first resistance level for the watch stands at $4.20 in the near term. At $4.42, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.57. If the price goes on to break the first support level at $3.82, it is likely to go to the next support level at $3.67. The third support level lies at $3.44 if the price breaches the second support level.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats
There are currently 48,833K shares outstanding in the company with a market cap of 195.72 million. Presently, the company’s annual sales total 100 K according to its annual income of -51,850 K. Last quarter, the company’s sales amounted to 40 K and its income totaled -6,670 K.
